Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.26 USD | +1.62% | +19.01% | -30.37% |
Evolution of the average Target Price on Travere Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Travere Therapeutics, Inc.
Wedbush | |
Stifel Nicolaus | |
Citigroup | |
JPMorgan Chase | |
Canaccord Genuity | |
Guggenheim | |
Evercore ISI | |
HC Wainwright | |
Wells Fargo Securities | |
William Blair & Co. | |
Piper Sandler | |
TD Cowen | |
BofA Securities | |
Barclays | |
SVB Securities LLC | |
SVB Leerink | |
BMO Capital |
EPS Revisions
- Stock Market
- Equities
- TVTX Stock
- Consensus Travere Therapeutics, Inc.